These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6297823)

  • 1. Enhancement of replication of Epstein-Barr virus DNA in human lymphoblastoid cell lines by N-methyl-N'-nitro-N-nitrosoguanidine.
    Lin JC; Smith MC; Pagano JS
    Carcinogenesis; 1983; 4(2):185-8. PubMed ID: 6297823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic action of retinoic acid against teleocidin and 12-O-tetradecanoyl-phorbol-13-acetate on activation of Epstein-Barr virus genomes.
    Lin JC; Smith MC
    Carcinogenesis; 1984 Apr; 5(4):483-7. PubMed ID: 6323048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells.
    Huang SY; Fang CY; Tsai CH; Chang Y; Takada K; Hsu TY; Chen JY
    Chem Biol Interact; 2010 Dec; 188(3):623-34. PubMed ID: 20869957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on chemical carcinogen enhancement of Epstein-Barr virus induced transformation of human neonatal and adult peripheral blood lymphocytes.
    Henderson EE; Fronko G
    Int J Cancer; 1984 Mar; 33(3):331-8. PubMed ID: 6321362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
    Stoerker J; Yajima Y; Glaser R
    Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication.
    Colby BM; Shaw JE; Elion GB; Pagano JS
    J Virol; 1980 May; 34(2):560-8. PubMed ID: 6246281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    Yajima Y; Nonoyama M
    J Virol; 1976 Jul; 19(1):187-94. PubMed ID: 181594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines.
    Shaw JE; Levinger LF; Carter CW
    J Virol; 1979 Feb; 29(2):657-65. PubMed ID: 219253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
    Lin JC; Raab-Traub N
    J Virol; 1987 Jun; 61(6):1985-91. PubMed ID: 3033325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of DNA synthesis inhibitors on early antigen expression following primary infection or superinfection by Epstein-Barr virus.
    Lidin BI; Lamon EW
    Arch Virol; 1983; 77(1):13-25. PubMed ID: 6312934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplicity-dependent biological and biochemical properties of Epstein-Barr virus (EBV) rescued from non-producer lines after superinfection with P3HR-1 EBV.
    Cho MS; Fresen KO; zur Hausen H
    Int J Cancer; 1980 Sep; 26(3):357-63. PubMed ID: 6270006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells.
    Fang CY; Huang SY; Wu CC; Hsu HY; Chou SP; Tsai CH; Chang Y; Takada K; Chen JY
    PLoS One; 2012; 7(9):e44810. PubMed ID: 23024765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation of 9([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human lymphoblastoid cell lines infected with Epstein-Barr virus.
    Lin JC; Nelson DJ; Lambe CU; Choi EI
    J Virol; 1986 Nov; 60(2):569-73. PubMed ID: 3021990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization polymorphism of EBV DNA genomes in the chromosomes of Burkitt lymphoma cell lines.
    Trescol-Biémont MC; Biémont C; Daillie J
    Chromosoma; 1987; 95(2):144-7. PubMed ID: 3036436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle.
    Szyf M; Eliasson L; Mann V; Klein G; Razin A
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8090-4. PubMed ID: 2999791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suitability of Epstein-Barr virus DNA obtained from superinfected Raji cells for complementary RNA hybridization studies.
    Tanaka A
    J Gen Virol; 1977 Feb; 34(2):375-9. PubMed ID: 190349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of activation of the Epstein-Barr virus genome on expression of B cell differentiation antigens of Burkitt's lymphoma lines.
    Yokochi T; Inoue Y; Iwata H; Miyadai T; Kimura Y
    Microbiol Immunol; 1988; 32(9):957-64. PubMed ID: 2850450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV.
    Kawanishi M
    Intervirology; 1995; 38(3-4):206-13. PubMed ID: 8682618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.
    Sato H; Takimoto T; Pagano JS; Raab-Traub N
    J Virol; 1988 Sep; 62(9):3288-94. PubMed ID: 2841481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.